Johnson & Johnson’s Vaccine Offers Strong Protection but Fuels Concern About Variants
Johnson & Johnson announced on Friday that its one-dose coronavirus vaccine provided strong protection against Covid-19, potentially offering the United States a third powerful tool in a desperate race against a worldwide rise in virus mutations. But the results came with a significant cautionary note: The vaccine’s efficacy rate dropped from 72 percent in the…